These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 16076871)
1. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. Salameh A; Galvagni F; Bardelli M; Bussolino F; Oliviero S Blood; 2005 Nov; 106(10):3423-31. PubMed ID: 16076871 [TBL] [Abstract][Full Text] [Related]
2. Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Galvagni F; Pennacchini S; Salameh A; Rocchigiani M; Neri F; Orlandini M; Petraglia F; Gotta S; Sardone GL; Matteucci G; Terstappen GC; Oliviero S Circ Res; 2010 Jun; 106(12):1839-48. PubMed ID: 20431062 [TBL] [Abstract][Full Text] [Related]
3. Molecular controls of lymphatic VEGFR3 signaling. Deng Y; Zhang X; Simons M Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF. Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450 [TBL] [Abstract][Full Text] [Related]
5. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis. Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323 [TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. Zhang X; Groopman JE; Wang JF J Cell Physiol; 2005 Jan; 202(1):205-14. PubMed ID: 15389531 [TBL] [Abstract][Full Text] [Related]
9. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Fujikawa K; de Aos Scherpenseel I; Jain SK; Presman E; Christensen RA; Varticovski L Exp Cell Res; 1999 Dec; 253(2):663-72. PubMed ID: 10585289 [TBL] [Abstract][Full Text] [Related]
10. c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1. Anselmi F; Orlandini M; Rocchigiani M; De Clemente C; Salameh A; Lentucci C; Oliviero S; Galvagni F Angiogenesis; 2012 Jun; 15(2):187-97. PubMed ID: 22327338 [TBL] [Abstract][Full Text] [Related]
11. Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism. Cattaneo MG; Lucci G; Vicentini LM Exp Cell Res; 2009 Nov; 315(18):3210-9. PubMed ID: 19563802 [TBL] [Abstract][Full Text] [Related]
12. Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress. Wang JF; Zhang X; Groopman JE J Biol Chem; 2004 Jun; 279(26):27088-97. PubMed ID: 15102829 [TBL] [Abstract][Full Text] [Related]
13. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
14. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781 [TBL] [Abstract][Full Text] [Related]
15. VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Nakatsu MN; Sainson RC; Pérez-del-Pulgar S; Aoto JN; Aitkenhead M; Taylor KL; Carpenter PM; Hughes CC Lab Invest; 2003 Dec; 83(12):1873-85. PubMed ID: 14691306 [TBL] [Abstract][Full Text] [Related]
16. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806 [TBL] [Abstract][Full Text] [Related]
18. VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells. Sakima M; Hayashi H; Mamun AA; Sato M Exp Cell Res; 2018 Jul; 368(1):13-23. PubMed ID: 29649427 [TBL] [Abstract][Full Text] [Related]
19. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Shen J; DiCorleto PE Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464 [TBL] [Abstract][Full Text] [Related]
20. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Favier B; Alam A; Barron P; Bonnin J; Laboudie P; Fons P; Mandron M; Herault JP; Neufeld G; Savi P; Herbert JM; Bono F Blood; 2006 Aug; 108(4):1243-50. PubMed ID: 16621967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]